138 related articles for article (PubMed ID: 3338370)
1. Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone.
Wallace JL; Whittle BJ
Dig Dis Sci; 1988 Feb; 33(2):225-32. PubMed ID: 3338370
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
Ibbotson GC; Wallace JL
J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes.
Wallace JL; MacNaughton WK
Eur J Pharmacol; 1988 Jun; 151(1):43-50. PubMed ID: 2843390
[TBL] [Abstract][Full Text] [Related]
4. Profile of gastrointestinal damage induced by platelet-activating factor.
Wallace JL; Whittle BJ
Prostaglandins; 1986 Jul; 32(1):137-41. PubMed ID: 3763942
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of prostaglandin E2 in endotoxic shock are unrelated to effects on PAF-acether synthesis.
Ibbotson GC; Wallace JL
Prostaglandins; 1989 Feb; 37(2):237-50. PubMed ID: 2727308
[TBL] [Abstract][Full Text] [Related]
6. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat.
Boughton-Smith NK; Hutcheson I; Whittle BJ
Prostaglandins; 1989 Sep; 38(3):319-33. PubMed ID: 2506613
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-induced gastric mucosal damage in the rat: possible role of platelet-activating factor.
Filep JG; Hermán F; Földes-Filep E; Schneider F; Braquet P
Br J Pharmacol; 1992 Apr; 105(4):912-8. PubMed ID: 1324056
[TBL] [Abstract][Full Text] [Related]
8. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B
Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134
[TBL] [Abstract][Full Text] [Related]
9. Castor oil increases intestinal formation of platelet-activating factor and acid phosphatase release in the rat.
Pinto A; Calignano A; Mascolo N; Autore G; Capasso F
Br J Pharmacol; 1989 Apr; 96(4):872-4. PubMed ID: 2743081
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor (PAF-acether) formation in neonatal intestinal mucosa and in cultured intestinal epithelial cells.
Kald B; Gustafson C; Franzén L; Weström B; Sjödahl R; Tagesson C
Eur Surg Res; 1992; 24(6):325-32. PubMed ID: 1292936
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration.
Wallace JL; Whittle BJ
Br J Pharmacol; 1986 Oct; 89(2):415-22. PubMed ID: 3096408
[TBL] [Abstract][Full Text] [Related]
12. Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants.
Wallace JL; Whittle BJ
Prostaglandins; 1986 May; 31(5):989-98. PubMed ID: 3726156
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor may mediate dexamethasone-induced gastric damage in the rat.
Filep J; Hermán F; Braquet P
Lipids; 1991 Dec; 26(12):1356-8. PubMed ID: 1819733
[TBL] [Abstract][Full Text] [Related]
14. Time course of PAF formation by gastrointestinal tissue in rats after castor oil challenge.
Pinto A; Autore G; Mascolo N; Sorrentino R; Biondi A; Izzo AA; Capasso F
J Pharm Pharmacol; 1992 Mar; 44(3):224-6. PubMed ID: 1354728
[TBL] [Abstract][Full Text] [Related]
15. Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.
Esplugues JV; Whittle BJ
Br J Pharmacol; 1988 Jan; 93(1):222-8. PubMed ID: 3349230
[TBL] [Abstract][Full Text] [Related]
16. Effects of stimulation and inhibition of acid secretion on gastric damage induced by platelet-activating factor.
Piqué JM; Pérez Ayuso RM; Bilbao J; Terés J
Dig Dis Sci; 1991 Dec; 36(12):1715-20. PubMed ID: 1748040
[TBL] [Abstract][Full Text] [Related]
17. Increased intestinal formation of Paf in endotoxin-induced damage in the rat.
Whittle BJ; Boughton-Smith NK; Hutcheson IR; Esplugues JV; Wallace JL
Br J Pharmacol; 1987 Sep; 92(1):3-4. PubMed ID: 3664090
[TBL] [Abstract][Full Text] [Related]
18. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations.
Braquet P; Etienne A; Mencia-Huerta JM; Clostre F
Eur J Pharmacol; 1988 Jun; 150(3):269-76. PubMed ID: 3046952
[TBL] [Abstract][Full Text] [Related]
19. Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat.
Martins MA; Silva PM; Castro HC; Neto F; Lima MC; Cordeiro RS; Vargaftig BB
Eur J Pharmacol; 1987 Apr; 136(3):353-60. PubMed ID: 3609124
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats.
Esplugues JV; Whittle BJ
Am J Physiol; 1989 Feb; 256(2 Pt 1):G275-82. PubMed ID: 2919672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
